DOJ Forms Health and Safety Unit for Criminal Enforcement

Note: This article is written for general informational purposes and is not legal advice. Companies facing regulatory or criminal enforcement questions should consult qualified counsel before making decisions. Translation: do not let your legal strategy be “we read a blog and felt brave.”

The U.S. Department of Justice has created a Health and Safety Unit inside the Criminal Division’s Fraud Section, and the message to companies is not exactly subtle: if your product can harm people, your compliance program can no longer live in a forgotten binder next to the office printer.

The new DOJ Health and Safety Unit, often shortened to HSU, is designed to pursue criminal enforcement involving public health, consumer safety, food and drug integrity, medical devices, transportation safety, and dangerous consumer products. In plain English, the unit is focused on situations where businesses or individuals allegedly ignore legal duties that exist to keep people from being injured, misled, poisoned, burned, defrauded, or otherwise treated like test subjects in a very bad science fair.

This development matters because it places health and safety misconduct squarely inside a major criminal enforcement structure. For regulated industries, the question is no longer only, “Will the FDA, CPSC, or another agency send us a warning letter?” The sharper question is, “Could this become a DOJ criminal matter?” That is the sort of question that makes boardrooms suddenly discover the joy of compliance training.

What Is the DOJ Health and Safety Unit?

The Health and Safety Unit is a DOJ Criminal Division unit focused on criminal cases involving violations of federal laws meant to protect public health and safety. Its work includes enforcement under the Federal Food, Drug, and Cosmetic Act, the Consumer Product Safety Act, the Federal Hazardous Substances Act, and related statutes.

The unit focuses on misconduct involving adulterated, misbranded, or counterfeit food, drugs, and devices; unsafe consumer products; transportation hazards; and failures to report known defects or dangers. That is a broad mandate, and it reaches well beyond classic “health care fraud.” A company does not need to bill Medicare to attract attention. Selling a defective product, hiding safety data, distributing contaminated products, or making significant misrepresentations to regulators or the public can be enough to raise the stakes.

Why the New Unit Matters

Federal health and safety enforcement has always existed, but the formation of a dedicated unit inside the Fraud Section gives these cases a more centralized criminal enforcement home. That matters for three big reasons: expertise, coordination, and visibility.

1. Expertise Is Now Concentrated

Health and safety cases are technically complex. Prosecutors may need to understand drug manufacturing rules, medical device approval pathways, product testing data, recall obligations, clinical trial records, supply chain documentation, or crash-related reporting requirements. A dedicated unit allows the DOJ to build institutional knowledge instead of treating each case like a mysterious box of cables nobody wants to untangle.

2. Agency Coordination Becomes More Powerful

The unit is expected to work closely with federal partners such as the Food and Drug Administration, the Consumer Product Safety Commission, transportation safety authorities, and other agencies. That means civil regulators and criminal prosecutors may operate in closer alignment when safety failures appear serious, intentional, repeated, or concealed.

3. Criminal Risk Becomes More Visible

For companies, the creation of the unit is a warning flare. A regulatory issue may begin with a customer complaint, adverse event report, failed inspection, internal audit finding, or whistleblower tip. If the facts suggest deception, concealment, falsified records, or knowing disregard of legal obligations, the matter may move from compliance headache to criminal exposure.

Industries Most Likely to Feel the Impact

The DOJ Health and Safety Unit can affect a wide range of industries. The most obvious are food, pharmaceuticals, medical devices, dietary supplements, tobacco, consumer goods, transportation, e-commerce, and manufacturing. But the unit’s reach may also extend to companies that provide testing, certification, logistics, quality control, labeling, packaging, data management, or regulatory consulting services.

In other words, the risk is not limited to the company whose name appears on the box. A third-party lab that falsifies safety results, a distributor that ignores contamination warnings, a consultant who helps conceal defects, or an executive who suppresses bad news may all become part of the story. And in DOJ stories, nobody wants to be the surprise character introduced in chapter seven.

Key Enforcement Areas to Watch

Food and Drug Safety

One of the Health and Safety Unit’s core responsibilities is criminal enforcement under the Federal Food, Drug, and Cosmetic Act. This includes cases involving adulterated or misbranded products, counterfeit drugs, unsafe manufacturing conditions, hidden contamination problems, and false statements about product safety or regulatory status.

For food and drug companies, the practical lesson is simple: quality systems are not decoration. Good manufacturing practices, sanitation controls, accurate batch records, supplier verification, complaint handling, and truthful labeling all matter. When companies treat those systems as optional paperwork, the DOJ may treat them as evidence.

Medical Devices

Medical device companies face particular risk because their products often affect patients directly. Misbranding, unapproved modifications, falsified testing, forged regulatory communications, or concealed device failures can become serious enforcement problems. A device that does not work as represented is not just a business dispute; it may become a patient safety issue.

Device manufacturers should pay close attention to design controls, adverse event reporting, quality audits, complaint investigations, and communications with regulators. If a device problem is serious enough to make engineers nervous, it should not be buried under a cheerful PowerPoint titled “Minor Field Feedback.”

Consumer Product Defects

The Health and Safety Unit also brings criminal cases involving dangerous consumer products and failures to report hazards. Under consumer product safety laws, companies may have obligations to report defects or risks that could cause injury or death. When a company learns that a product may be unsafe, the clock does not politely pause while executives “circle back next quarter.”

Examples in this area may involve defective appliances, children’s products, batteries, tools, furniture, electronics, household goods, or other products that create serious hazards. A pattern of complaints, injury reports, fires, failures, or near misses can become highly relevant. The worst strategy is to treat customer complaints like annoying background noise. Sometimes the background noise is the smoke alarm.

Transportation Safety

The unit’s stated focus also includes transportation safety. This can involve failures to comply with reporting obligations, concealment of safety defects, false certifications, or conduct that increases risk on roads, in logistics operations, or in regulated transportation systems.

Companies involved in vehicles, parts, fleet operations, shipping, or transportation services should review how they detect, escalate, and report safety issues. In the transportation world, paperwork failures can have real-world consequences, and regulators tend to notice when “minor issue” becomes “major incident.”

What Makes a Case Criminal?

Not every safety failure becomes a criminal case. Products can fail, systems can break, and even careful companies can make mistakes. Criminal enforcement usually becomes more likely when the facts suggest knowledge, concealment, repeated violations, falsified records, misleading statements, obstruction, or willful disregard of legal duties.

For example, a company that discovers a contamination issue and immediately investigates, reports, recalls, and fixes the root cause is in a very different position from a company that hides the test results, ships the product anyway, and tells customers everything is “premium quality.” One is a compliance problem. The other is a prosecutor’s bedtime story.

How the DOJ Unit Changes Corporate Compliance

The formation of the Health and Safety Unit should push companies to rethink compliance as an operating function, not a legal ornament. Compliance must connect quality assurance, regulatory affairs, legal, safety, engineering, supply chain, finance, and executive leadership. If those teams do not talk to each other, regulators may eventually do the talking for them.

Companies should review how safety information moves internally. Who receives complaints? Who decides whether an issue must be reported? Who has authority to stop shipments? Who reviews promotional claims? Who checks whether a distributor is selling products in a way that creates regulatory risk? Who makes sure the company is not relying on “Bob knows the process” as its entire compliance architecture?

Practical Compliance Steps for Companies

Build a Real Escalation System

Companies need a clear process for escalating health and safety concerns. Employees should know when a complaint, defect report, lab result, inspection finding, or adverse event must be elevated. The escalation process should be written, trained, tested, and actually used. A policy that exists only in a shared drive nobody opens is basically a ghost with bullet points.

Protect Internal Reporting Channels

Whistleblower tips and internal complaints can trigger enforcement scrutiny, especially when companies ignore them. Businesses should make it easy for employees to report safety concerns without fear of retaliation. More importantly, companies should investigate those concerns seriously. The worst internal report is not the one that creates work; it is the one that gets ignored and later becomes Exhibit A.

Document Decisions Honestly

Documentation matters. But documentation must be accurate, complete, and honest. Companies should avoid vague meeting notes, sanitized summaries, or “creative” quality records that make reality look prettier than it is. Regulators and prosecutors are very good at comparing emails, test results, shipping records, and meeting minutes. If the documents tell five different stories, nobody will applaud the company’s literary range.

Review Supplier and Third-Party Risk

Many safety failures begin outside the company’s walls. Suppliers may provide contaminated ingredients, defective components, inaccurate certifications, or incomplete testing. Third-party distributors may create labeling, storage, or handling problems. Companies should review contracts, audit rights, quality agreements, and supplier monitoring systems before a third party’s mistake becomes the brand owner’s emergency.

Train Executives, Not Just Compliance Staff

Health and safety enforcement risk is not only a compliance department issue. Senior leaders, product managers, sales teams, quality personnel, and operations managers all need training. Executives must understand that decisions about recalls, reporting, shipment holds, labeling, and product claims can carry criminal implications. “We did not know” is much less persuasive when nobody bothered to ask.

Examples of Conduct That Can Create DOJ Attention

Several patterns are especially likely to draw scrutiny from a criminal health and safety enforcement unit. These include shipping products after failed safety tests, changing records after an inspection, hiding contamination results, failing to report known hazards, selling products with false certifications, distributing counterfeit or unauthorized medical products, making misleading claims about drugs or devices, and obstructing agency investigations.

The common thread is not merely that something went wrong. The common thread is that someone allegedly knew or should have known about a serious risk and chose delay, concealment, or deception. That is where compliance failures can become criminal problems.

What This Means for Consumers

For consumers, the new unit may sound like another Washington acronym, but its mission is practical. People rely on food labels, drug quality, device safety, product warnings, and recall systems every day. Most consumers do not have a laboratory in the kitchen, a crash-test facility in the garage, or a regulatory lawyer sitting beside the cereal box. Federal enforcement exists because ordinary people cannot personally verify every safety claim made by every company.

When criminal enforcement works well, it discourages companies from treating safety rules as a cost-benefit game. It also rewards companies that invest in real controls, accurate reporting, and responsible remediation. The best outcome is not more prosecutions. The best outcome is fewer dangerous products reaching people in the first place.

What This Means for Corporate Leaders

Corporate leaders should treat the DOJ Health and Safety Unit as a signal that safety-related misconduct may receive more focused criminal attention. Boards and executives should ask direct questions: Are we meeting reporting obligations? Are we tracking complaints properly? Are we reviewing safety data honestly? Are we prepared to stop sales when necessary? Are our public claims supported by evidence?

These questions may feel uncomfortable, but they are much more comfortable than answering them for the first time during a government investigation. Good compliance is like good dental care: a little routine discomfort beats a surprise root canal.

The Role of Voluntary Disclosure

The DOJ has continued to emphasize corporate voluntary self-disclosure, cooperation, and remediation in criminal enforcement policy. For companies facing potential health and safety violations, this means the timing and quality of internal response can matter significantly.

When a company discovers misconduct, it should quickly preserve evidence, investigate facts, stop ongoing harm, assess reporting duties, discipline responsible individuals where appropriate, improve controls, and consider whether voluntary disclosure is warranted. That decision is complex and should be made with experienced legal counsel. The main point is that silence, delay, and wishful thinking are not a strategy. They are a strategy-shaped hole.

Why the Unit Could Shape Future Enforcement

The Health and Safety Unit could influence enforcement in several ways. It may increase consistency in criminal health and safety cases. It may strengthen coordination with agencies that identify safety violations first. It may also give prosecutors a clearer platform for pursuing individuals, not just companies, when the facts support personal accountability.

That last point is important. Modern DOJ corporate enforcement often looks beyond the corporate entity to the people who made, approved, concealed, or ignored critical decisions. A company may pay a penalty, but individuals can face charges if prosecutors believe they knowingly violated the law. The corporate logo cannot be the only character in the courtroom.

Experience-Based Insights: What Companies Should Learn Now

In practical compliance experience, the biggest health and safety problems rarely begin with a dramatic villain speech. They usually start with small signals: a customer complaint that sounds unusual, a test result that does not fit the expected pattern, a supplier certificate that arrives late, a field report that mentions a recurring defect, or an employee who says, “I do not think we should ship this yet.” At that moment, a company has a choice. It can slow down and investigate, or it can keep moving and hope the issue behaves itself. Spoiler: issues do not behave themselves.

One common lesson is that companies often underestimate the importance of internal communication. The quality team may know one piece of the problem, the sales team another, customer service another, and legal another. Individually, each piece looks manageable. Together, they form a flashing neon sign reading “regulatory risk.” A strong compliance system connects those pieces before a regulator does.

Another experience-based lesson is that culture beats policy. A company can have a beautiful compliance manual, complete with color-coded tabs and language so polished it could run for office. But if employees believe management only rewards speed, sales, and silence, the manual will not save anyone. Workers must believe that raising safety concerns is valued, not punished. Managers must be trained to pause shipments, escalate concerns, and document decisions accurately, even when the business pressure is intense.

Companies also learn, sometimes painfully, that early transparency is usually cheaper than late panic. When a safety problem appears, responsible leaders gather facts quickly, preserve documents, involve legal and regulatory experts, and take immediate steps to reduce risk. Less responsible leaders ask whether the problem can be “handled quietly.” That phrase has aged poorly in many investigations.

For startups and fast-growing companies, the lesson is especially important. Growth can outpace controls. A small team may begin with informal processes, then suddenly find itself selling nationwide through distributors, online platforms, and retail partners. What worked at 5,000 units may fail badly at 500,000 units. Health and safety compliance must grow with the business. Otherwise, the company ends up driving a race car with bicycle brakes.

For larger companies, the challenge is different. Big organizations may have many systems but poor visibility. Data sits in silos. Complaints are coded inconsistently. Regional teams interpret reporting duties differently. Senior leaders receive summaries that smooth out the sharp edges. The Health and Safety Unit’s formation should encourage large companies to test whether their reporting systems reveal bad news quickly or bury it politely.

The most useful takeaway is simple: treat safety information like mission-critical information. If a product could hurt people, the company should know who reviews the data, who makes decisions, who reports to regulators, who communicates with customers, and who verifies that corrective actions actually work. Companies that can answer those questions calmly are in a stronger position. Companies that answer with “Let me check who owns that” may have some homework to do.

Conclusion

The DOJ’s formation of the Health and Safety Unit is more than an internal government reshuffle. It is a clear sign that criminal enforcement involving public health and product safety will remain a serious priority. The unit brings focus to cases involving adulterated food and drugs, counterfeit products, unsafe medical devices, dangerous consumer goods, transportation hazards, concealed safety data, and failures to report known risks.

For businesses, the lesson is not to panic. The lesson is to prepare. Companies should strengthen compliance systems, improve internal reporting, document honestly, train leaders, review third-party risk, and respond quickly when safety concerns arise. A strong safety culture is not just good ethics; it is legal risk management with a hard hat on.

For consumers, the new unit reinforces an important principle: companies that profit from products affecting public health and safety must take those responsibilities seriously. The marketplace works best when innovation, speed, and profit do not trample the basic promise that products should be safe, accurately labeled, and responsibly monitored.